Constance Mubekapi (PhD Cand.)
Scientific Director
PhD Candidate, MPH & MPhil
cm@clinigma.com
About
Constance brings over 15 years of specialized expertise in socio-behavioral public health research and clinical trials analysis to CLINIGMA®. As Scientific Director of Analysis, she leads the rigorous transformation of qualitative patient interview data into actionable evidence that drives clinical development decisions.
Expertise
Clinical Trials Research Leadership
- Extensive experience as Senior Research Associate in international clinical trials
- Deep expertise in both qualitative and quantitative research methods across communicable and non-communicable diseases
Advanced Analytical Capabilities
- Master of Philosophy in Programme Evaluation with specialized training in research methodology
- Master of Public Health with focus on population-level health interventions
- Currently completing PhD in Public Health, advancing cutting-edge analytical approaches
- Expert in implementation science and health research translation
International Research Portfolio
- Co-investigator and project manager on major NIH-funded studies including the landmark HPTN 071 (PopART) trial
- Published researcher with contributions to high-impact journals including Journal of the International AIDS Society and PLOS One
- Proven experience conducting research across diverse populations in Zambia, South Africa, Tanzania, and Namibia
Specialized Disease Expertise
- HIV/AIDS Research: Deep experience in prevention strategies, stigma assessment, and treatment adherence studies
- Rare Diseases: Specialized knowledge in patient experience research for uncommon conditions
- Public Health Interventions: Expert in community-based research and population health strategies
Constance's commitment to authentic patient voice representation, combined with her strategic understanding of clinical development needs, delivers insights that truly matter for in-trial interview success.
Publications
Constance Mubekapi-Musadaidzwa, Dillon Wademan, Neshaan Peton, … Graeme Hoddinott on behalf of the HPTN 071 (PopART) Study Team. (Submitted to Journal). Motivating PLHIV to initiate ART outside national guidelines in three clinics in the HPTN 071 (PopART) trial, South Africa. AJAR.
A. Stangl, T. Pliakas, T. Mainga, M. Steinhaus, C. Mubekapi-Musadaidzwa, …, J.R. Hargreaves on behalf of the HPTN 071 (PopART) study team. (2020). The effect of universal testing and on HIV in 21 communities in Zambia and South Africa: results from a cluster randomised trial. AIDS
Hargreaves JR, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, … Ayles H on behalf of the HPTN 071 (PopART) study team. (2020). HIV stigma and viral suppression among PLHIV in the context of universal test and treat: data analysis from the HPTN 071 (PopART) trial in Zambia and South Africa. Journal of Acquir Immune Defic Syndr
Kwame Shanaube, Ab Schaap, Graeme Hoddinott, Constance Mubekapi-Musadaidzwa, … Helen Ayles on behalf of the HPTN 071 (PopART) Study Team. (2020). Impact of a community-wide HIV combination prevention intervention on knowledge of HIV status among adolescents: Primary results of HPTN 071 (PopART) for Youth Study
V Bond, S Nomsenge, M Mwamba, D Ziba, A Birch, C Mubekapi-Musadaidzwa, … J Seeley on behalf of the HPTN 071 (PopART) study team (2018) “Being seen” at the clinic: Zambian and South African health worker reflections on the relationship between health facility place, space and HIV stigma in 21 health facilities, the HPTN 071 (PopART) study. Health and Place
Mubekapi-Musadaidzwa C, Macleod D, Mwate J, C, Vanqa N, …, Hoddinott G on behalf of the HPTN 071 study team (In progress). Factors associated with sexual behaviours of increased risk of HIV among adolescents in HPTN 071 (PopART) study communities in South Africa and Zambia
C Mubekapi-Musadaidzwa, H Myburgh, R Casper, D Macleod,… G Hoddinott on behalf of the HPTN 071 study team (In progress). HIV-related stigma towards young people– a critical analysis of adolescent and health worker surveys and qualitative data from the HPTN 071 (PopART) trial in Zambia and South Africa
© Copyright 2025
CLINIGMA® All rights reserved